Acyclovir
Active substance: acyclovir
INJECTION, SOLUTION · ACYCLOVIR SODIUM 50 mg/mL
United StatesActive
Marketing holder: Fresenius Kabi USA, LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- ACYCLOVIR SODIUM · 50 mg/mL
Registration
- Registration number
- 63323-325
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 63323-325 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63323-325 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63323-325 · Verified 2026-10-09 · open in source